Virologist treats breast cancer with oncolytic virotherapy, shrinking the tumor and boosting immune response. An ...

Patients with dMMR colon cancer in a trial for two neoadjuvant cycles of nivolumab/ipilimumab or nivolumab/relatlimab, had ...

The median event-free survival was not reached in the durvalumab arm and was 46.1 months in the control arm. Incorporating ...

Dongan Hills resident Melissa Hickey turned her chemotherapy sessions into carnivals, movie sets and tea parties.

Nurse navigators and APPs are key members of the multidisciplinary team who can lead and implement QI efforts to ensure ...

The 22nd Annual Winter Lung Cancer Conference, January 31-February 2, 2025, will cover advances in NSCLC and SCLC treatment.

Atossa Therapeutics has strong financials with $79.5 million in cash and a cash runway of 13-14 quarters, minimizing ...

They reported these findings in Cancer Cell. On study, patients received neoadjuvant vidutolimod (at 5 mg subcutaneously on week 1 followed by 6 doses of 10 mg intratumorally weekly) and nivolumab (3 ...

IMNN-001 immunotherapy plus standard-of-care chemotherapy resulted in 35% improvement in overall survival and 25% improvement in progression-free ...

Moderna Chief Human Resources Officer Tracey Franklin has expanded her role to Chief People and Digital Technology Officer, overseeing the Company's talent and digital functions. Brad Miller, Chief ...

The following is a summary of “Pathologic complete response (pCR) rates for patients with HR+/HER2- high-risk, early-stage ...